Why CACI International (CACI) is a Promising Portfolio Pick Now
https://www.zacks.com/stock/news/2205098/why-caci-international-caci-is-a-promising-portfolio-pick-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2205098
Jan 03, 2024 - CACI International (CACI) appears to be an attractive investment at the moment, with healthy fundamentals and strong long-term growth drivers.
0
Here's Why You Should Bet on Rigel Pharmaceuticals (RIGL) Now
https://www.zacks.com/stock/news/2205099/here-s-why-you-should-bet-on-rigel-pharmaceuticals-rigl-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2205099
Jan 03, 2024 - Here, we discuss some reasons why buying Rigel Pharmaceuticals (RIGL) stock now may turn out to be a prudent move.
0
Here's Why Flowserve (FLS) Stock is an Attractive Pick Now
https://www.zacks.com/stock/news/2205082/here-s-why-flowserve-fls-stock-is-an-attractive-pick-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2205082
Jan 03, 2024 - Flowserve (FLS) is set to benefit from strong MRO and aftermarket activity. The company's measures to reward its shareholders are encouraging.
0
Why Community Health (CYH) Shares Are Attracting Investors Now
https://www.zacks.com/stock/news/2205023/why-community-health-cyh-shares-are-attracting-investors-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2205023
Jan 03, 2024 - We expect Community Health's (CYH) occupancy rate to continue moving upward, reflecting improving utilization of its facilities and services.
0
Are Investors Undervaluing Amcor (AMCR) Right Now?
https://www.zacks.com/stock/news/2204995/are-investors-undervaluing-amcor-amcr-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_2-2204995
Jan 03, 2024 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
0
Is Custom Truck One Source (CTOS) Stock Undervalued Right Now?
https://www.zacks.com/stock/news/2204998/is-custom-truck-one-source-ctos-stock-undervalued-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_2-2204998
Jan 03, 2024 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
0
Are Investors Undervaluing Ardmore Shipping (ASC) Right Now?
https://www.zacks.com/stock/news/2205004/are-investors-undervaluing-ardmore-shipping-asc-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_2-2205004
Jan 03, 2024 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
0
Reasons to Add General Dynamics (GD) to Your Portfolio Now
https://www.zacks.com/stock/news/2204971/reasons-to-add-general-dynamics-gd-to-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2204971
Jan 03, 2024 - General Dynamics (GD), with its stable ROE and rising earnings estimates, makes a strong case for investment in the Aerospace Defense space.
0
Reasons to Retain ShockWave Medical (SWAV) in Your Portfolio Now
https://www.zacks.com/stock/news/2204955/reasons-to-retain-shockwave-medical-swav-in-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2204955
Jan 03, 2024 - ShockWave Medical (SWAV) continues to benefit from solid R&D endeavors and its commitment to clinical studies.
0
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
https://www.zacks.com/stock/news/2204891/why-investors-need-to-take-advantage-of-these-2-medical-stocks-now?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_earnings_esp-2204891
Jan 03, 2024 - Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
0